News Daily News Frail Older Patients With AF May Fare Better Switching to DOAC Todd Neale August 05, 2025
News Daily News Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools Todd Neale March 19, 2025
News Daily News DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF Todd Neale March 06, 2025
News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025
News Daily News Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea Todd Neale August 27, 2024
News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Daily News Off-label DOAC Dosing Tied to Worse Adherence, More Discontinuation Todd Neale June 14, 2023
News Daily News Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, Boosts Hemostasis Todd Neale June 05, 2023
News Daily News Generic Dabigatran Lots Pulled for Nitrosamine Impurity Michael O'Riordan March 28, 2023
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Initiative Lowers Unnecessary Aspirin Use in Warfarin Users Todd Neale September 26, 2022
News Daily News Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit Todd Neale August 17, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021